HG (n = 23) | Non-SIT (n = 10) | SCIT (n = 33) | |
---|---|---|---|
Age (years) | |||
Mean ± SD | 28 ± 9 | 27 ± 7 | 31 ± 11 |
Range | 18–50 | 19–39 | 17–61 |
Gender | |||
Male | 52.2% (n = 12) | 30% (n = 3) | 57.6% (n = 19) |
Female | 47.8% (n = 11) | 70% (n = 7) | 42.4% (n = 14) |
Clinical parameters | |||
Time from disease onset (years) | NA | 10 ± 7 | 12 ± 8 |
Time under SCIT (months) | NA | NA | 28 ± 13 |
Presence of Asthma | NA | 40% (n = 4) | 43% (n = 13) |
Laboratorial parameters | |||
Total serum IgE (t-IgE) (kU/L) | NA | 295 ± 231 | 514 ± 787 |
Serum specific IgE (s-IgE) (kUA/L) | NA | 48 ± 27 | 45 ± 35 |